CD8A and COVID-19: They also observed mild inflammation and enhanced epithelial barrier function, along with an increased CD8+ T cell response, in asymptomatic COVID-19 patients, compared with symptomatic patients, which may explain the absence of symptoms in a proportion of COVID-19 patients [112].